Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1269664
Max Phase: Preclinical
Molecular Formula: C34H27N5O10S2
Molecular Weight: 729.75
Molecule Type: Small molecule
Associated Items:
ID: ALA1269664
Max Phase: Preclinical
Molecular Formula: C34H27N5O10S2
Molecular Weight: 729.75
Molecule Type: Small molecule
Associated Items:
Synonyms (1): NSC-47754
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cc(-c2ccc(/N=N/c3c(S(=O)(=O)O)cc4cc(N)ccc4c3O)c(OC)c2)ccc1/N=N/c1cc(S(=O)(=O)O)c2ccccc2c1O
Standard InChI: InChI=1S/C34H27N5O10S2/c1-48-28-14-18(7-11-25(28)36-38-27-17-30(50(42,43)44)23-5-3-4-6-24(23)33(27)40)19-8-12-26(29(15-19)49-2)37-39-32-31(51(45,46)47)16-20-13-21(35)9-10-22(20)34(32)41/h3-17,40-41H,35H2,1-2H3,(H,42,43,44)(H,45,46,47)/b38-36+,39-37+
Standard InChI Key: DAUWYVUKZMSMCP-NFSGFYSESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 729.75 | Molecular Weight (Monoisotopic): 729.1199 | AlogP: 7.99 | #Rotatable Bonds: 9 |
Polar Surface Area: 243.12 | Molecular Species: ACID | HBA: 13 | HBD: 5 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: -2.79 | CX Basic pKa: 3.51 | CX LogP: 5.05 | CX LogD: 2.28 |
Aromatic Rings: 6 | Heavy Atoms: 51 | QED Weighted: 0.05 | Np Likeness Score: -0.16 |
1. Sierecki E, Sinko W, McCammon JA, Newton AC.. (2010) Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening., 53 (19): [PMID:20836557] [10.1021/jm100331d] |
Source(1):